BANDARAM
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Bandaram Pharma Packtech Re-Appoints Deepak Reddy Bandaram As Chairman, MD
Sept 5 (Reuters) - Bandaram Pharma Packtech Ltd BPPL.BO:
RE-APPOINTS DEEPAK REDDY BANDARAM AS CHAIRMAN AND MD
Source text: ID:nBSElhR37
Further company coverage: BPPL.BO
Sept 5 (Reuters) - Bandaram Pharma Packtech Ltd BPPL.BO:
RE-APPOINTS DEEPAK REDDY BANDARAM AS CHAIRMAN AND MD
Source text: ID:nBSElhR37
Further company coverage: BPPL.BO
Bandaram Pharma Packtech Approves Acquisition Of 84.21% Stake In Craftsmart Products
June 20 (Reuters) - Bandaram Pharma Packtech Ltd BPPL.BO:
ACQUISITION OF 84.21% STAKE IN CRAFTSMART PRODUCTS
ACQUISITION ON SWAP BASIS VIA ISSUE OF UPTO 6 MILLION SHARES
Source text: ID:nBSE9wmDPp
Further company coverage: BPPL.BO
June 20 (Reuters) - Bandaram Pharma Packtech Ltd BPPL.BO:
ACQUISITION OF 84.21% STAKE IN CRAFTSMART PRODUCTS
ACQUISITION ON SWAP BASIS VIA ISSUE OF UPTO 6 MILLION SHARES
Source text: ID:nBSE9wmDPp
Further company coverage: BPPL.BO
Events:
Dividend
Dividend
Dividend
Rights
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Bandaram Pharma Pack do?
Bandaram Pharma Packtech Limited, formerly known as Shiva Medicare Limited, is an Indian company incorporated in 1993. It is engaged in the trading of paper.
Who are the competitors of Bandaram Pharma Pack?
Bandaram Pharma Pack major competitors are Biofil Chem & Pharma, Mangalam Drugs&Org., Rajnish Wellness, Vivimed Labs, Walpar Nutritions, Vilin Bio Med, Panjon. Market Cap of Bandaram Pharma Pack is ₹45 Crs. While the median market cap of its peers are ₹46 Crs.
Is Bandaram Pharma Pack financially stable compared to its competitors?
Bandaram Pharma Pack seems to be less financially stable compared to its competitors. Altman Z score of Bandaram Pharma Pack is 2.7 and is ranked 5 out of its 8 competitors.
Does Bandaram Pharma Pack pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Bandaram Pharma Pack latest dividend payout ratio is 21.95% and 3yr average dividend payout ratio is 18.88%
How has Bandaram Pharma Pack allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Bandaram Pharma Pack balance sheet?
Balance sheet of Bandaram Pharma Pack is moderately strong.
Is the profitablity of Bandaram Pharma Pack improving?
Yes, profit is increasing. The profit of Bandaram Pharma Pack is ₹0.59 Crs for TTM, ₹0.55 Crs for Mar 2025 and ₹0.52 Crs for Mar 2024.
Is the debt of Bandaram Pharma Pack increasing or decreasing?
Yes, The net debt of Bandaram Pharma Pack is increasing. Latest net debt of Bandaram Pharma Pack is ₹21.52 Crs as of Sep-25. This is greater than Mar-25 when it was ₹17.02 Crs.
Is Bandaram Pharma Pack stock expensive?
Bandaram Pharma Pack is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Bandaram Pharma Pack is 112, while 3 year average PE is 85.62. Also latest EV/EBITDA of Bandaram Pharma Pack is 25.32 while 3yr average is 26.13.
Has the share price of Bandaram Pharma Pack grown faster than its competition?
Bandaram Pharma Pack has given better returns compared to its competitors. Bandaram Pharma Pack has grown at ~-17.63% over the last 2yrs while peers have grown at a median rate of -26.66%
Is the promoter bullish about Bandaram Pharma Pack?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Bandaram Pharma Pack is 62.62% and last quarter promoter holding is 75.0%
Are mutual funds buying/selling Bandaram Pharma Pack?
There is Insufficient data to gauge this.
